RxDoctor Payments Data

Joseph Craft, MD

Cardiovascular Disease · Saint Louis, MONPI 1568423721

Payments from drug & device makers

$80in general payments, 2019–2025

Across 5 payments — averaging $15.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi-aventis U.S. LLC$37
  • Pfizer$15
  • Abbott$14
  • Akcea Therapeutics, Inc.$14

What the payments were for

  • Food & beverage$80100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$80 in reported general payments places this provider in the 10th percentile of 391 cardiovascular disease providers in Missouri.

See all cardiovascular disease providers in Missouri

Medicare billing

Part B allowed, 2024
$380,539
Medicare patients
1,797
Services billed
7,306

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban815$862,078
EntrestoSacubitril/Valsartan214$244,267
XareltoRivaroxaban163$162,340
Repatha SureclickEvolocumab115$97,771
FarxigaDapagliflozin Propanediol102$88,281
MultaqDronedarone Hcl74$71,829
JardianceEmpagliflozin61$62,393
Dofetilide30$7,412
Repatha SyringeEvolocumab13$7,092
Metoprolol Succinate660$6,383
Rosuvastatin Calcium555$5,848
Ranolazine ErRanolazine34$5,087
Atorvastatin Calcium511$4,531
Carvedilol657$4,324
Losartan Potassium531$4,027

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$15$862,078815 claims
Sanofi-aventis U.S. LLCMultaq$37$71,82974 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 10th percentile of 391 cardiovascular disease providers in Missouri.

Other cardiovascular disease in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →